When patients with Clostridium difficile colitis do not respond to usual treatment ... has excellent in vitro activity against C. difficile. Now, they report success using tigecycline to treat ...
Recurrent C. diff infection is when you contract a C. diff infection 2 to 8 weeks after completing treatment for a previous one. C. diff relapse is a recurrence of the same strain, while ...
FMT restores gut microbiota balance by transferring stool from healthy donors, mainly for recurrent C. difficile infections. Recent data shows FMT's high efficacy in preventing recurrent C.
Ulcerative colitis usually causes diarrhea, which may be watery and appear fluffy, mushy, or bloody. You may also experience constipation, which may present as small, hard stool lumps. Ulcerative ...
Pfizer's vaccine for Clostridium difficile (C. diff) looks like it may join a growing list of candidates that have been shelved or delayed, after the shot failed to meet its primary objective in a ...
In vitro, nitazoxanide has shown excellent activity against C. difficile. In one study, the 90% MIC (MIC 90) of the toxigenic strains of C. difficile was 0.5 µg/mL for nitazoxanide, which was ...
The therapy re-establishes a healthy microbial community, preventing recurrent Clostridioides difficile infections by outcompeting pathogenic bacteria. The panelist discusses how Rebyota is an FDA ...
The product is based on purified Firmicutes bacterial spores delivered in an oral capsule that is designed to encourage the regrowth of healthy bacteria after antibiotic treatment for C.
If you've been diagnosed with ulcerative colitis, your treatment plan will take into consideration your specific symptoms and how long you have had the disease. A variety of over-the-counter and ...
The Pediatric Inflammatory Bowel Disease (IBD) Center at Johns Hopkins Children’s Center is committed to providing comprehensive and compassionate care for children with Crohn’s disease, ulcerative ...